Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Clinical trial NCT02662062 · COMPLETED
Trial details
- NCT number
- NCT02662062
- Sponsor
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-11
- Primary completion
- 2022-05-12
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.